Private equity firm THL Partners has agreed to buy a majority stake in Headlands Research, a U.S.-based network of clinical ...

Private equity firm THL Partners has agreed to buy a majority stake in Headlands Research, a U.S.-based network of clinical ...

THL Partners ("THL"), a premier private equity firm investing in middle market growth companies, today announced the entry ...

THL Partners has agreed to acquire Headlands Research, a Lake Worth, Florida-based network of clinical trial sites, from KKR. No financial terms were disclosed. The transaction is expected to close in ...

Daiichi Sankyo signs a $300m deal with Alteogen to develop a subcutaneous version of anti-HER2 cancer drug Enhertu.